RXRα (S427F/Y) mutations drive the proliferation of urothelial organoids in the absence of tumor suppressor genes and strengthen the interaction between RXRα and PPARγ, activating the PPARγ/RXRα pathway 68, and downregulating the expression of a series of proinflammatory chemokines. This evidence concerns the gene RXRA and neoplasm.